Skip to content

Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma

Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00459849
Enrollment
175
Registered
2007-04-13
Start date
2000-07-31
Completion date
2007-07-31
Last updated
2008-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveal Melanoma

Keywords

Melanoma, Brachytherapy, Ultrasonography

Brief summary

Plaque radiotherapy is a common treatment for uveal melanoma. However, local failure has been reported in up to 20% of patients. We use intraoperative ultrasonography at plaque insertion and removal to evaluate plaque movement as a potential factor in local failure.

Detailed description

Episcleral plaque radiotherapy is a common treatment for uveal melanoma and results in local tumor control in most cases. However, local failure has been reported in a substantial proportion of patients. Since local failure greatly increases the risk of metastatic death, identifying and correcting the causes of local treatment failure are of paramount importance. Poor plaque localization is an important contributing factor to local failure. With the aid of intraoperative ultrasonography, most malpositioned plaques can be identified and readjusted at the time of plaque insertion. However, little is known about plaque movement during the 4-5 days of brachytherapy, which could also contribute to local failure. To address this question, we perform intraoperative B-scan ultrasonography at the time of iodine-125 radioactive plaque insertion and removal in uveal melanoma patients.

Interventions

PROCEDUREIntraoperative ultrasonography

Intraoperative ultrasonography will be used to determine plaque placement.

Sponsors

Barnes Retina Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with uveal melanoma treated with brachytherapy

Exclusion criteria

* Ciliary melanoma

Design outcomes

Primary

MeasureTime frame
Plaque tilt using intraoperative ultrasonographyEnd of study
Local melanoma failureEnd of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 6, 2026